ʻO Candida Albicans Nucleic Acid

ʻO ka wehewehe pōkole:

Kuhi ʻia kēia pahu no ka ʻike in vitro o Candida Albicans nucleic acid i ka hoʻohemo ʻana a me nā laʻana sputum.

 


Huahana Huahana

Huahana Huahana

inoa huahana

HWTS-FG001A-Candida Albicans Nucleic Acid Detection Kit (Fluorescence PCR)

Epidemiology

ʻO nā ʻano ʻano Candida ka nui o nā mea kanu fungal maʻamau i loko o ke kino kanaka. Aia ia i loko o ka ʻōpū hanu, ka ʻāpana digestive, ka ʻāpana urogenital a me nā ʻāpana ʻē aʻe e kamaʻilio me ka honua o waho. ʻO ka maʻamau, ʻaʻole ia he pathogenic a no ka bacteria pathogenic opportunistic. Ma muli o ka hoʻohana nui ʻana o ka immunosuppressant a me ka nui o nā lāʻau lapaʻau ākea ākea, a me ka radiotherapy tumor, chemotherapy, invasive treatment, organ transplantation, ʻaʻole ibalanced ka flora maʻamau a loaʻa ka maʻi candida i ka ʻāpana genitourinary a me ka ʻōpū hanu.

ʻO ka maʻi Candida o ka ʻāpana genitourinary hiki ke hoʻopilikia i nā wahine i ka Candida vulva a me ka vaginitis, kahi e hoʻopilikia nui ai i ko lākou ola a me ka hana. Ke piʻi nei ka maʻi o ka maʻi genital candidiasis i kēlā me kēia makahiki, i waena o nā wahine genital tract ʻo Candida maʻi ma kahi o 36%, a ʻo nā kāne genital tract Candida maʻi ma kahi o 9%, ma waena o lākou, ʻo Candida albicans (CA) ka maʻi maʻamau, helu ma kahi o 80%. ʻO ka maʻi fungal, maʻamau ʻo Candida albicans, kahi kumu nui o ka make i loaʻa i ka haukapila, a ʻo ka maʻi CA ma kahi o 40% o nā maʻi ICU. Ma waena o nā maʻi fungal visceral a pau, ʻo nā maʻi fungal pulmonary ka mea maʻamau, a ke piʻi nei ke ʻano i kēlā me kēia makahiki. ʻO ka hoʻomaʻamaʻa mua ʻana a me ka ʻike ʻana i nā maʻi fungal pulmonary he mea koʻikoʻi koʻikoʻi.

Kanal

FAM ʻO Candida Albicans
VIC/HEX Hoomalu Kuloko

Nā ʻāpana ʻenehana

Waihona ≤-18 ℃
Kau-ola 12 mahina
ʻAno Hoʻohālike Hoʻokuʻu ʻia o ka ʻōpū, Sputum
Ct ≤38
CV ≤5.0%
LoD 1×103Nā kope/mL
kikoo ʻAʻohe ʻano hoʻohālikelike me nā maʻi pathogens maʻi genitourinary ʻē aʻe e like me Candida tropicalis, Candida glabrata, Trichomonas vaginalis, Chlamydia trachomatis, Ureaplasma urealyticum, Neisseria gonorrhoeae, Group B Streptococcus, herpes simplex virus type 2 a me nā maʻi maʻi ʻē aʻe o ka maʻi pathogenic respiratory e like me adenoculosis tuberculosis. nā maʻi maʻi a me nā hōʻailona sputum kanaka maʻamau
Nā mea hana pili Hoʻohana ʻia ʻo Biosystems 7500 Pūnaehana PCR manawa maoli

QuantStudio®5 Pūnaehana PCR Manawa maoli

SLAN-96P Pūnaehana PCR Manawa maoli

LightCycler®480 Pūnaehana PCR manawa maoli

LineGene 9600 Plus Pūnaehana ʻike PCR manawa maoli

MA-6000 Mea Hoʻokele Thermal Cycler manawa maoli

BioRad CFX96 Pūnaehana PCR Manawa maoli

BioRad CFX Opus 96 Pūnaehana PCR Manawa maoli

Holo Hana

Koho 1.

Manaʻo ʻia nā mea hoʻihoʻi hou: Macro & Micro-Test Sample Release Reagent (HWTS-3005-8)

Koho 2.

Manaʻo ʻia nā reagents unuhi: Macro & Micro-Test Viral DNA/RNA Kit (HWTS-3001, HWTS-3004-32, HWTS-3004-48, HWTS-3004-96) a me Macro & Micro-Test Automatic Nucleic Acid Extractor(HWTS-3006)


  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou